Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.

Authors

Landon Carter Brown

Duke Cancer Institute, Durham, NC

Susan Halabi , Joseph Schonhoft , Jun Luo , David M. Nanus , Paraskevi Giannakakou , Russell Zelig Szmulewitz , Daniel Costin Danila , Patrick Healy , Monika Anand , Jason Somarelli , Howard I. Scher , Rick Wenstrup , William R. Berry , Scott T. Tagawa , Emmanuel S. Antonarakis , Daniel J. George , Andrew J. Armstrong , Landon Carter Brown

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

Poster Details

Meeting

2020 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Tumor Biology, Biomarkers, and Pathology

Clinical Trial Registration Number

NCT02269982

Citation

J Clin Oncol 38, 2020 (suppl 6; abstr 183)

Abstract #

183

Poster Bd #

H19

Abstract Disclosures

FEATURED

Association of circulating tumor cell chromosomal instability with worse outcomes in men with mCRPC treated with abiraterone or enzalutamide.

Authors

Landon Carter Brown

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.